SCHEMBL7315720

SCHEMBL7315720

Cc1ccc(C2(O)c3ccccc3C=Cc3ccccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 6/20 0.46
KDM4E B2RXH2 1/20 0.41
PKM P14618 1/20 0.41
OPRM1 P35372 3/20 0.38
OPRK1 P41145 2/20 0.38
OPRL1 P41146 2/20 0.38
PDK2 Q15119 3/20 0.35
P2RX1 P51575 1/20 0.35
P2RX3 P56373 1/20 0.35
P2RX4 Q99571 1/20 0.35
P2RX7 Q99572 1/20 0.35
OPRD1 P41143 1/20 0.35
MDM2 Q00987 1/20 0.35
OXTR P30559 1/20 0.34
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
ALOX12 P18054 1/20 0.33
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1758080 0.87 OPRM1 (0.42) KIF11OPRM1OPRK1OPRL1PDK2
SCHEMBL7322102 0.85 P2RX1 (0.46) KIF11KDM4EPKMPDK2P2RX1
SCHEMBL7312957 0.82 LMNA (0.43) KIF11KDM4EPKMOPRM1OPRK1
SCHEMBL7320511 0.82 PDK2 (0.47) KIF11KDM4EOPRM1OPRK1OPRL1
SCHEMBL7322612 0.77 CHRM3 (0.45) OPRM1OPRK1OPRL1PDK2P2RX1
SCHEMBL7310248 0.77 BCHE (0.39) KIF11OPRM1OPRK1OPRL1PDK2
SCHEMBL11451560 0.76 ELANE (0.44) KIF11PDK2MDM2
SCHEMBL30838726 0.74 PDK2 (0.44) KIF11OPRM1OPRK1OPRL1PDK2
SCHEMBL28617342 0.74 PDK2 (0.44) KIF11OPRM1OPRK1OPRL1PDK2
SCHEMBL9644144 0.72 PDK2 (0.42) KIF11KDM4EPKMPDK2MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 US disclosed
WO-1999041227-A1 TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS ALLELIX NEUROSCIENCE, INC. (US) 1999-08-19 WO disclosed